Apollo Therapeutics

Business financing
#Apollo Therapeutics #Drug discovery #Funding

Apollo Therapeutics closes $226.5 million Series C financing 

Apollo Therapeutics, a biopharmaceutical company focused on translating fundamental medical research into medicines through a hub-and-spoke approach, has closed $226.5 million in a Series C financing, led by lead investor Patient Square Capital.  Financing significantly adds to the $195 million previously raised by the company, and to… Read More

#Business & Investment #News